Dr Desmond Hau, CEO of Pangenia Inc, sits down with PharmaBoardroom to shed light on the company’s progress since taking the reins three years ago. Hau also explains Pangenia’s strategy to develop their brand in South East Asia, the changes he foresees for the industry post the COVID-19 pandemic, and the need for consolidation amongst small diagnostics testing companies.
My personal mission is to position Pangenia to be one of the largest molecular diagnostics companies based in Hong Kong, facing the South East Asian market
